Ignite Creation Date:
2025-12-24 @ 2:01 PM
Ignite Modification Date:
2026-07-13 @ 12:52 PM
Study NCT ID:
NCT07052695
Status:
RECRUITING
Last Update Posted:
2025-12-15
First Post:
2025-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mosunetuzumab for CLL MRD Clearance
Sponsor:
Organization: